Anti-CD79B Monoclonal Antibody-MMAE Conjugate DCDS4501A

An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against B-cell antigen receptor complex-associated protein beta chain (CD79B) conjugated, via a protease-cleavable peptide linker, to monomethyl auristatin E (MMAE), an auristatin derivative and a potent microtubule inhibitor, with potential antineoplastic activity. Upon administration, the monoclonal antibody moiety of DCDS4501A selectively binds to CD79B, a protein which is abundantly expressed on the surface of B-cells. Upon internalization and proteolytic cleavage, MMAE binds to tubulin and inhibits its polymerization, resulting in G2/M phase arrest and tumor cell apoptosis. CD79B, a component of the B-cell receptor (BCR), plays a key role in B-cell receptor signaling and is expressed on the surface of almost all types of malignant B-cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

Anti-CD70 Monoclonal Antibody MDX-1411

A glycoengineered, fully humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Anti-CD70…

Anti-CD70 Monoclonal Antibody ARGX-110

A defucosylated, humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Upon administration,…

Anti-CD70 Antibody-Drug Conjugate MDX-1203

An antibody-drug conjugate (ADC) containing a fully human monoclonal antibody, directed against the extracellular domain of the human CD70 molecule, conjugated to…

Anti-CD7 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD7, regardless of the antibody type.

Anti-CD7 Immunotoxin

A toxin linked to an anti-CD7 antibody.

Anti-CD6 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD6, regardless of the antibody type.